# Epetraborole in Patients With Mycobacterium Abscessus Lung Disease

> **NCT07301320** · PHASE2 · RECRUITING · sponsor: **Kevin Winthrop** · enrollment: 84 (estimated)

## Conditions studied

- Mycobacterium Abscessus Infection

## Interventions

- **DRUG:** Epetraborole
- **DRUG:** Epetraborole
- **DRUG:** Placebo
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT07301320
- **Lead sponsor:** Kevin Winthrop
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-03-30
- **Primary completion:** 2027-12
- **Final completion:** 2028-05
- **Target enrollment:** 84 (ESTIMATED)
- **Last updated:** 2026-05-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07301320

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07301320, "Epetraborole in Patients With Mycobacterium Abscessus Lung Disease". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT07301320. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*